Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet

Topics

Biology

Biochemistry

Medicine

Internal Medicine

Neurology

Show all topics

DOI

10.1016/s0140-6736(20)32661-1

License

CC-BY

Other Formats

PDF